Ethosuximide Capsule
Product Images NDC 62135-790

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ethosuximide (NDC 62135-790). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Ethosuximide Capsules 250mg Label)

Image Description (Ethosuximide Capsules 250mg Label)
The label is for Ethosuximide Capsules, USP, 250 mg oral capsules by Chartwell RX, LLC. It indicates a quantity of 120 capsules, prescription only, with directions to dispense the medication guide separately to each patient. The label includes the NDC 62135-790-12 and storage and dosage information, along with a barcode and a note specifying 'No Varnish' on the label varnish.*
FDA Label Image

Image Description (Ethosuximide Structure)

Image Description (Ethosuximide Structure)
Chemical structure of Ethosuximide, showing a succinimide ring with an ethyl and methyl substituent attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.